FOLLOWUS
Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment
Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment
- 中国结合医学杂志（英文版） 2009年15卷第6期 页码：462-465
- Affiliations：
1. The First Traditional Chinese Medicine Hospital of Zhanjiang City,Guangdong,China
2. Guangdong Medical College,Guangdong,China
- Author bio：
- Funds：
DOI：10.1007/s11655-009-0462-8
中图分类号：纸质出版日期：2009，
网络出版日期：2010-1-18，
Scan for full text
Fu, Xx., Xiao, Wj., Lu, J. et al. Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment., Chin. J. Integr. Med. 15, 462–465 (2009). https://doi.org/10.1007/s11655-009-0462-8
Xiao-xia Fu, Wen-jian Xiao, Jian Lu, et al. Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment[J]. Chinese Journal of Integrative Medicine, 2009,15(6):462-465.
Fu, Xx., Xiao, Wj., Lu, J. et al. Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment., Chin. J. Integr. Med. 15, 462–465 (2009). https://doi.org/10.1007/s11655-009-0462-8 DOI：
Xiao-xia Fu, Wen-jian Xiao, Jian Lu, et al. Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment[J]. Chinese Journal of Integrative Medicine, 2009,15(6):462-465. DOI： 10.1007/s11655-009-0462-8.
摘要
To explore the cardiac protective effect of integrative therapy in acute myocardial infarction (AMI) with elevated ST segment after reperfusion. Sixty-four AMI patients who having received decimalization by thrombolysis were assigned to two groups by retrospective analysis
36 patients in the treated group and 28 in the control group. Both were treated by intravenous administering of urokinase for thrombolysis
and to the treated group
intravenous dripping of Xueshuantong Injection (血栓通注射液
XST) was added. Serum levels of myocardial associated enzymes were monitored before treatment and at various time points after thrombolysis
and the heart function parameters were detected with color echocardiography before treatment and on the 7th and 14th day of treatment. The patients were followed up for 6 months to observe the incidence of cardiac events. The differences between groups at the peak and peak appearing time of creatine kinase and creatine kinase isoenzyme were not significant. All the heart function parameters on the 7th and 14th day in the treated group were improved and superior to those at the corresponding time points in the control group (P<0.05
P<0.01). Incidence of some heart events in the treated group within the 6-month follow-up period was lesser than that in the control group (P<0.05). XST Injection could provide effective protection for the heart after reperfusion.
Abstract
To explore the cardiac protective effect of integrative therapy in acute myocardial infarction (AMI) with elevated ST segment after reperfusion. Sixty-four AMI patients who having received decimalization by thrombolysis were assigned to two groups by retrospective analysis
36 patients in the treated group and 28 in the control group. Both were treated by intravenous administering of urokinase for thrombolysis
and to the treated group
intravenous dripping of Xueshuantong Injection (血栓通注射液
XST) was added. Serum levels of myocardial associated enzymes were monitored before treatment and at various time points after thrombolysis
and the heart function parameters were detected with color echocardiography before treatment and on the 7th and 14th day of treatment. The patients were followed up for 6 months to observe the incidence of cardiac events. The differences between groups at the peak and peak appearing time of creatine kinase and creatine kinase isoenzyme were not significant. All the heart function parameters on the 7th and 14th day in the treated group were improved and superior to those at the corresponding time points in the control group (P<0.05
P<0.01). Incidence of some heart events in the treated group within the 6-month follow-up period was lesser than that in the control group (P<0.05). XST Injection could provide effective protection for the heart after reperfusion.
关键词
acute myocardial infarction with elevated ST-segmentintegrative medical therapyXueshuantong Injection
Keywords
acute myocardial infarction with elevated ST-segmentintegrative medical therapyXueshuantong Injection
references
Ye RG, Lu ZY, edis. Internal medicine. 6th ed. Beijing: People’s Medical Publishing House; 2006:283–297.
Editorial board of Chinese Journal of Cardiology. Reference scheme of thrombolytic therapy of acute myocardial infarction. Chin J Cardiol (Chin) 1996;24:318–329.
He J. Research progress in pharmacological action of panax notoginseng. Tianjin Pharm (Chin) 2004;16:58–59.
Guo XH, Gao WY, Jia W, Duan HQ, Xiao PG. Research progress in pharmacological action and clinical application of chemical constituents of panax notoginseng. Chin Pract Med J (Chin) 2004;15:12.
Tang XD, Jiang JQ, Lin CW, Liu BY, Jiang DC, Gu DY. Experimental study on effects of total saponins of Panax Notoginseng on activation of NF-κb and infiltration of PMN in myocardial ischemic-reperfusion injury. J Chengdu Univ Tradit Chin Med (Chin) 2002;25:36.
Cui JT. Prevention and treatment of Panax Notoginseny on cariovascular diseases. Chin J Hosp Pharm (Chin) 1999;19:37.
Li XC. Research progress in Chinese herbs on antimyocardiali schemia injury. Chin J Modern Appl Pharm (Chin) 1998;15:1–4
Liu XP. Clinical observation on effects of panax notoginsenosidum on angina pectoris. J Emerg Tradit Chin Med (Chin) 2000;9:147.
Yu JZ, Guo DA. The proper timing of sero-enzyme examination in the thrombolytic therapy of AMI. Hainan Med J (Chin) 2004;15:9–10.
Cui JF, Pan BS. Serum enzymes markers evolution of acute myocardial infarction. Shanghai J Med Lab Sci (Chin) 2005;15:48–52.
Newby LK, Goldmann BU, Ohman EM. Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2003;41(4Suppl):31S–36S.
Khan SQ, Kelly D, Quinn P, Davies JE, Ng LL. Cardiotrophin-I predicts death or heart failure following acute myocardial infarction. J Card Fail 2006;12:635–640.
Zhang JN, Yang GP, Su EB, Xu JD, Bian ZP, Ma WZ, et al. Study on the diagnostic of serum cardiac troponin I in acute myocardial infarction. Chin J Cardiol (Chin) 1997; 25:379–382.
Hedstrom E, Astrom-Olsson K, Ohlin H, Frogner F, Carlsson M, Billgren T, et al. Peak CK-Mb and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc 2007;41:44–50.
Gao RL. Present situation and progress in the research into drug eluting stents. Chin J Pract Intern Med (Chin) 2006;26:1211.
0
浏览量
349
Downloads
5
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
